Skip to main content

Table 2 Emergence profiles by group. Values are mean (SD) or numbers (proportion)

From: Staggering the dose of sugammadex lowers risks for severe emergence cough: a randomized control trial

 

Sugammadex 1 + 1 mg/kg group

Sugammadex 2 mg/kg group

Neostigmine group

p-value

n = 40

n = 40

n = 40

Emergence time; min

6.0 (3.2)

5.9 (2.5)

6.6 (3.7)

0.625

Reversal time; min

6.5 (3.5)

6.4 (4.5)

6.9 (3.4)

0.809

Emergence cough; n

 No cough

1 (2.5)

0

1 (2.5)

<0.001

 Mild (single cough)

17 (42.5)

4 (10.0)

23 (57.5)

 Moderate (lasting < 5 s)

17 (42.5)

8 (20.0)

9 (22.5)

 Severe (sustained > 5 s)

5 (12.5)

28 (70.0)

7 (17.5)

Sedation level; n

 RSS 1

6 (15.0)

14 (35.0)

3 (7.5)

0.005

 RSS 2&3

34 (85.0)

26 (65.0)

37 (92.5)

  1. Emergence time, time taken from discontinuation of anesthesia till administration of reversal agent; reversal time, time taken from administration of reversal agent until tracheal extubation
  2. RSS Ramsay Sedation Scale